CN Patent

CN115531560B — 用于制备超声波造影剂的方法及装置

Assigned to Lantheus Medical Imaging Inc · Expires 2024-05-17 · 2y expired

What this patent protects

本申请涉及用于制备超声波造影剂的方法及装置。本发明提供用于识别及/或区分UCA调配物，且特定而言用于活化这类调配物以产生适用于活体内使用的UCA的方法及装置。

USPTO Abstract

本申请涉及用于制备超声波造影剂的方法及装置。本发明提供用于识别及/或区分UCA调配物，且特定而言用于活化这类调配物以产生适用于活体内使用的UCA的方法及装置。

Drugs covered by this patent

Patent Metadata

Patent number
CN115531560B
Jurisdiction
CN
Classification
—
Expires
2024-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Lantheus Medical Imaging Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.